Molecular assembly for high-performance bivalent nucleic acid inhibitor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 15, 2008, Pages 5664-5669

  Kim, Youngmi ^a   Cao, Zehui ^a   Tan, Weihong ^a  

^a University of Florida ^*  (United States)

Author keywords

Anticogulation; Aptamers; Multivalent binding; Thrombin

Indexed keywords

APTAMER; LIGAND; NUCLEIC ACID; PROTEIN INHIBITOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; GENE CONTROL; GENETIC ENGINEERING AND GENE TECHNOLOGY; HUMAN; KINETICS; LIGHT SCATTERING; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ANTIDOTES; APTAMERS, NUCLEOTIDE; DRUG DESIGN; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; KINETICS; PROTEIN BINDING;

EID: 43949098703     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711803105     Document Type: Article

References (28)

1. Mammen M, Choi S-K, Whitesides GM (1998) Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37:2755-2794.
2. Yuan CL, Reiko TL (1995) Carbohydrate-protein interactions - Basis of glycobiology. Acc Chem Res 28:321-327.
3. Chen H, Privalsky ML (1995) Cooperative formation of high-order oligomers by retinoid X receptors: An unexpected mode of DNA recognition. Proc Natl Acad Sci USA 92:422-426.
4. Kortt AA, Dolezal O, Power BE, Hudson PJ (2001) Dimeric and trimeric antibodies: High avidity scFvs for cancer targeting. Biomol Eng 18:95-108.
5. Wolf E, Hofmeister R, Kufer P, Schlereth B, Baeuerle PA (2005) BiTEs: Bispecific antibody constructs with unique anti-tumor activity. Drug Discovery Today 10:1237-1244.
6. Wolf E, Baeuerle PA (2002) Micromet: Engaging immune cells for life. Drug Discovery Today 7:S25-S27.
7. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510.
8. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822.
9. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564-566.
10. DeAnda A, Jr, et al. (1994) Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann Thorac Surg 58:344-350.
11. Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Leung LL (1993) In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood 81:3271-3276.
12. 165): Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273:20556-20567.
13. Huang J, et al. (2001) Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg 36:357-360.
14. Li JWJ, Fang XH, Schuster SM, Tan WH (2002) Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun 292:31-40.
15. Nirnjee SM, Rusconi CP, Harrington RA, Sullenger BA (2005) The potential of aptamers as anticoagulants. Trends Cardiovasc Med 15:41-45.
16. Rusconi CP, et al. (2002) RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419:90-94.
17. Hirsh J (2003) Current anticoagulant therapy - unmet clinical needs. Thromb Res 109(Suppl 1):S1-S8.
18. Di Nisio M, Middeldorp S, Buller HR (2005) Drug therapy - Direct thrombin inhibitors. N Engl J Med 353:1028-1040.
19. Tasset DM, Kubik MF, Steiner W (1997) Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol 272:688-698.
20. German I, Buchanan DD, Kennedy RT (1998) Aptamers as ligands in affinity probe capillary electrophoresis. Anal Chem 70:4540-4545.
21. Berezovski M, Nutin R, Li Y, Krylov SN (2003) Affinity analysis of a protein-aptamer complex using nonequilibrium capillary electrophoresis of equilibrium mixtures. Anal Chem 75:1382-1386.
22. Kazunori I, Yuji O, Koichi S, Isao K (2005) A novel method of screening thrombin-inhibiting DNA aptamers using an evolution-mimicking algorithm. Nucleic Acids Res 33:e108.
23. Rickles FR, Patierno S, Fernandez PM (2003) Tissue factor, thrombin, and cancer. Chest 124:58S-68S.
24. Langdell RD, Wagner RH, Brinkhous KM (1953) Effect of antihemophilic factor on one-stage clotting tests; A presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med 41:637-647.
25. Quick AJ, Stanley-Browne M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501-511.
26. Shangguan D, et al. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103:11838-11843.
27. Tang Z, et al. (2007) Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem 79:4900-4907.
28. Huang Y-F, Chang H-T, Tan W (2008) Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 80:567-572.